Lonza Group AG
LZAGY · OTC
Market closed$70.18$-0.770000 (-1.09%)After hours $70.18 · 0.00%
Key statistics
Previous close$70.95
Open$70.76
Day high$70.76
Day low$69.91
52-week high$73.85
52-week low$58.53
Market cap49.94B
Volume1.48K
Average volume64.42K
P/E ratio38.27
Forward P/E—
EPS1.83
Dividend yield+0.88%
Market context
Why it moved
LZAGY shares edged lower amid broad market caution and thin trading volume, with no major company-specific catalysts to provide upward momentum.
What is happening
Recent company-specific developments and publisher coverage.
ad-hoc-news.de · July 18, 2026Lonza Group stock holds focus on earnings and margin trendsNutraceutical Business Review · July 17, 2026Lonza Capsugel marks 25 years of UC-II collagen as joint health ingredient demand continues to growFinimize · July 15, 2026RBC Thinks Lonza’s CDMO Discount Doesn’t Fit Its GrowthFierce Pharma · July 4, 2026Lonza expands partnership with US drugmaker, boosts capacity for ADCsPR Newswire · July 1, 2026Nona Biosciences and Lonza Enter Strategic Collaboration to Develop Best-in-Class Single-Domain Antibody-Based BBB-Crossing Technology for CNS Diseasesad-hoc-news.de · June 30, 2026Lonza Group expands ADC capacity in Visp as demand for complex biologics growsThe Business Journals · June 29, 2026Swiss drug manufacturer may build $1B Clermont County facilityAd Hoc News · May 12, 2026Lonza Group AG stock (CH0013841017): Morningstar upgrades to buy